236 related articles for article (PubMed ID: 30597066)
1. Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset Inflammatory Bowel Disease.
Kariyawasam VC; Kim S; Mourad FH; Selinger CP; Katelaris PH; Brian Jones D; McDonald C; Barr G; Chapman G; Colliwshaw J; Lunney PC; Middleton K; Wang RR; Huang T; Andrews J; Pathirana PW; Leong RW
Inflamm Bowel Dis; 2019 Jul; 25(8):1390-1398. PubMed ID: 30597066
[TBL] [Abstract][Full Text] [Related]
2. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
3. Systematic Review and Meta-analysis: Phenotype and Clinical Outcomes of Older-onset Inflammatory Bowel Disease.
Ananthakrishnan AN; Shi HY; Tang W; Law CC; Sung JJ; Chan FK; Ng SC
J Crohns Colitis; 2016 Oct; 10(10):1224-36. PubMed ID: 26928965
[TBL] [Abstract][Full Text] [Related]
4. Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity.
Niewiadomski O; Studd C; Hair C; Wilson J; Ding NS; Heerasing N; Ting A; McNeill J; Knight R; Santamaria J; Prewett E; Dabkowski P; Dowling D; Alexander S; Allen B; Popp B; Connell W; Desmond P; Bell S
J Gastroenterol Hepatol; 2015 Sep; 30(9):1346-53. PubMed ID: 25867770
[TBL] [Abstract][Full Text] [Related]
5. Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study.
Mañosa M; Calafat M; de Francisco R; García C; Casanova MJ; Huelín P; Calvo M; Tosca J; Fernández-Salazar L; Arajol C; Zabana Y; Bastida G; Hinojosa J; Márquez L; Barreiro-de-Acosta M; Calvet X; Monfort D; Gómez-Garcia MR; Rodríguez E; Huguet JM; Rojas-Feria M; Hervias D; Atienza R; Busquets D; Zapata E; Dueñas C; Charro M; Martínez-Cerezo FJ; Plaza R; Vázquez JM; Gisbert JP; Cañete F; Cabré E; Domènech E;
Aliment Pharmacol Ther; 2018 Mar; 47(5):605-614. PubMed ID: 29369387
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Disease Phenotype and Course among Elderly- and Early-Onset Inflammatory Bowel Diseases in the Middle East.
Vosoghinia H; Saberzadeh-Ardestani B; Anushiravani A; Mansour-Ghanaei F; Fakheri H; Vahedi H; Sheikhesmaeili F; Yazdanbod A; Moosavy SH; Maleki I; Nasseri-Moghaddam S; Khosravi B; Malekzadeh M; Kasaeian A; Alatab S; Sadeghi A; Kolahdoozan S; Amani M; Saberhosseini SN; Rayatpisheh M; Ahadi M; Colombel JF; Ungaro RC; Sima AR; Malekzadeh R
Arch Iran Med; 2023 Sep; 26(9):481-488. PubMed ID: 38310403
[TBL] [Abstract][Full Text] [Related]
7. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study.
Charpentier C; Salleron J; Savoye G; Fumery M; Merle V; Laberenne JE; Vasseur F; Dupas JL; Cortot A; Dauchet L; Peyrin-Biroulet L; Lerebours E; Colombel JF; Gower-Rousseau C
Gut; 2014 Mar; 63(3):423-32. PubMed ID: 23408350
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age-An Increasing Distinct Entity?
Jeuring SF; van den Heuvel TR; Zeegers MP; Hameeteman WH; Romberg-Camps MJ; Oostenbrug LE; Masclee AA; Jonkers DM; Pierik MJ
Inflamm Bowel Dis; 2016 Jun; 22(6):1425-34. PubMed ID: 26933752
[TBL] [Abstract][Full Text] [Related]
9. Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study.
Alexakis C; Saxena S; Chhaya V; Cecil E; Curcin V; Pollok R
Inflamm Bowel Dis; 2017 Apr; 23(4):672-680. PubMed ID: 28151735
[TBL] [Abstract][Full Text] [Related]
10. Progression of Elderly Onset Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Population-Based Cohort Studies.
Rozich JJ; Dulai PS; Fumery M; Sandborn WJ; Singh S
Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2437-2447.e6. PubMed ID: 32142940
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and Natural History of Elderly-onset Inflammatory Bowel Disease: Results From a Territory-wide Hong Kong IBD Registry.
Mak JWY; Lok Tung Ho C; Wong K; Cheng TY; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Ng SC
J Crohns Colitis; 2021 Mar; 15(3):401-408. PubMed ID: 32914171
[TBL] [Abstract][Full Text] [Related]
12. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
Biancone L; Armuzzi A; Scribano ML; Castiglione F; D'Incà R; Orlando A; Papi C; Daperno M; Vecchi M; Riegler G; Fries W; Alvisi P; Meucci G; Mocciaro F; Rogai F; Festa S; Guidi L; Testa A; Spina L; Renna S; Viola A; Patturelli M; Di Mitri R; Frankovic I; Calabrese E; Petruzziello C; De Cristofaro E; Sena G; Ruffa A; Neri B; Rossi A
Inflamm Bowel Dis; 2020 Feb; 26(3):450-459. PubMed ID: 31498388
[TBL] [Abstract][Full Text] [Related]
13. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.
Biancone L; Armuzzi A; Scribano ML; D'Inca R; Castiglione F; Papi C; Angelucci E; Daperno M; Mocciaro F; Riegler G; Fries W; Meucci G; Alvisi P; Spina L; Ardizzone S; Petruzziello C; Ruffa A; Kohn A; Vecchi M; Guidi L; Di Mitri R; Renna S; Emma C; Rogai F; Rossi A; Orlando A; Pallone F;
J Crohns Colitis; 2016 Aug; 10(8):913-24. PubMed ID: 26933032
[TBL] [Abstract][Full Text] [Related]
15. Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia.
Ng SC; Zeng Z; Niewiadomski O; Tang W; Bell S; Kamm MA; Hu P; de Silva HJ; Niriella MA; Udara WS; Ong D; Ling KL; Ooi CJ; Hilmi I; Lee Goh K; Ouyang Q; Wang YF; Wu K; Wang X; Pisespongsa P; Manatsathit S; Aniwan S; Limsrivilai J; Gunawan J; Simadibrata M; Abdullah M; Tsang SW; Lo FH; Hui AJ; Chow CM; Yu HH; Li MF; Ng KK; Ching JY; Chan V; Wu JC; Chan FK; Chen M; Sung JJ;
Gastroenterology; 2016 Jan; 150(1):86-95.e3; quiz e13-4. PubMed ID: 26385074
[TBL] [Abstract][Full Text] [Related]
16. Hospitalisation, surgical and medical recurrence rates in inflammatory bowel disease 2003-2011—a Danish population-based cohort study.
Vester-Andersen MK; Vind I; Prosberg MV; Bengtsson BG; Blixt T; Munkholm P; Andersson M; Jess T; Bendtsen F
J Crohns Colitis; 2014 Dec; 8(12):1675-83. PubMed ID: 25154681
[TBL] [Abstract][Full Text] [Related]
17. Risk of Surgery and Mortality in Elderly-onset Inflammatory Bowel Disease: A Population-based Cohort Study.
Nguyen GC; Bernstein CN; Benchimol EI
Inflamm Bowel Dis; 2017 Feb; 23(2):218-223. PubMed ID: 27997435
[TBL] [Abstract][Full Text] [Related]
18. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
[TBL] [Abstract][Full Text] [Related]
19. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
20. Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy.
Chen C; Hartzema AG; Xiao H; Wei YJ; Chaudhry N; Ewelukwa O; Glover SC; Zimmermann EM
Inflamm Bowel Dis; 2019 Jul; 25(8):1417-1427. PubMed ID: 30839057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
